Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier

• Main Authors: Takizawa Y. (Author), Kato A. (Author), Onsui A. (Author), Kanatanai S. (Author), Ishimura A. (Author), Kurita T. (Author), Nakajima T. (Author)
• Format: Book
• Published: Sciendo, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

While many types of diabetes medications are currently available, orally administered formulations of glucagon-like peptide-1 (GLP-1) receptor agonists have recently been launched. Therefore, gastrointestinal epithelial cells will be increasingly exposed to GLP-1 receptor agonists; however, their ef...